Search for Clinical Trial Results
Malignant Carcinoid Syndrome - 25 Studies Found
Status | Study |
Completed |
Study Name: Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors Condition: Carcinoid Tumors Date: 2004-07-30 Interventions: Drug: Pasireotide (SOM230) Open label. Patients received starting dose of 300 µg of study drug subc |
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition:
Date: 2008-01-25 Interventions:
|
Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition:
|
Completed |
Study Name: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery Condition:
|
Completed |
Study Name: Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors Condition:
|